Last reviewed · How we verify
Fexofenadine HCl Coated tablet — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Fexofenadine HCl Coated tablet (Fexofenadine HCl Coated tablet) — Opella Healthcare Group SAS, a Sanofi Company.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Fexofenadine HCl Coated tablet TARGET | Fexofenadine HCl Coated tablet | Opella Healthcare Group SAS, a Sanofi Company | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Fexofenadine HCl Coated tablet CI watch — RSS
- Fexofenadine HCl Coated tablet CI watch — Atom
- Fexofenadine HCl Coated tablet CI watch — JSON
- Fexofenadine HCl Coated tablet alone — RSS
Cite this brief
Drug Landscape (2026). Fexofenadine HCl Coated tablet — Competitive Intelligence Brief. https://druglandscape.com/ci/fexofenadine-hcl-coated-tablet. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab